here is my guess as to what is going on. The first time they dropped the exercise price on the warrants to entice warrant holders to buy shares it did not work. At that time there was not as many near term catalysts and the expiration of the warrants was not as close. I hope this time it does bring in some cash and lessen the number of warrants. This not only raises cash but could stop the selling of shares to hold warrants. The other good thing is that it reduces the pressure to get some deal done, at bad SP terms. I would hate to give away too much just to meet the burn rate for a short time.


As for the hiring of a deal maker, this tells me they did have offers on t he table and once counter offers were made - the deals fell apart. We should have had someone this entire time chasing these opportunities and not let them fail. The increase in share count and expanding the stock awards program is purely to get this talent ASAP, which they have. Any past talk from Nader about partnership/licensing deals should be tossed out. I am happy this is now being taken seriously, finally we will have someone with sole responsibility to forge partnerships. I think many believe Nader is not very talented in this but he is committed to this company and getting someone with the right skill set is what a good CEO should do.


I am a little upset that this process of getting a good partnership is just now happening, however we are going to have many PRs to support the conversations with BP and VC firms now.

As for the selling pressure today - I have no clue why. I just hope these actions wash out whatever is causing this wacked-out SP. I am tired of reminding myself of just how undervalued this is and that one day everything will change. This drug should be easy to create huge value and this past year has made me wonder what am I missing.